Baotou Dongbao Bio-Tech Co Ltd
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private la… Read more
Baotou Dongbao Bio-Tech Co Ltd (300239) - Total Liabilities
Latest total liabilities as of September 2025: CN¥851.75 Million CNY
Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has total liabilities worth CN¥851.75 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Baotou Dongbao Bio-Tech Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Baotou Dongbao Bio-Tech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PetroVietnam Power Nhon Trach 2 JSC
VN:NT2
|
Vietnam | ₫4.42 Trillion |
|
PWR Holdings Limited
PINK:PWRHF
|
USA | $106.73 Million |
|
Gedik Yatirim Menkul Degerler AS
IS:GEDIK
|
Turkey | TL15.30 Billion |
|
Whirlpool of India Limited
NSE:WHIRLPOOL
|
India | ₹23.97 Billion |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
China | CN¥142.19 Million |
|
Danal Co. Ltd
KQ:064260
|
Korea | ₩519.07 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Baotou Dongbao Bio-Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baotou Dongbao Bio-Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baotou Dongbao Bio-Tech Co Ltd (2008–2024)
The table below shows the annual total liabilities of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥885.50 Million | +4.32% |
| 2023-12-31 | CN¥848.82 Million | +53.70% |
| 2022-12-31 | CN¥552.26 Million | +8.59% |
| 2021-12-31 | CN¥508.58 Million | +21.16% |
| 2020-12-31 | CN¥419.75 Million | +30.16% |
| 2019-12-31 | CN¥322.48 Million | -28.00% |
| 2018-12-31 | CN¥447.86 Million | +85.24% |
| 2017-12-31 | CN¥241.78 Million | +111.58% |
| 2016-12-31 | CN¥114.27 Million | +55.48% |
| 2015-12-31 | CN¥73.50 Million | -61.32% |
| 2014-12-31 | CN¥190.01 Million | +13.00% |
| 2013-12-31 | CN¥168.16 Million | +4.30% |
| 2012-12-31 | CN¥161.23 Million | +97.51% |
| 2011-12-31 | CN¥81.63 Million | -16.38% |
| 2010-12-31 | CN¥97.62 Million | -8.42% |
| 2009-12-31 | CN¥106.60 Million | +4.26% |
| 2008-12-31 | CN¥102.24 Million | -- |